Catalyst Wire Dossier Catalyst Wire Dossier

Puxitatug Samrotecan

AZD8205 · AstraZeneca
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Puxitatug Samrotecan, covering 2026-03-09 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) [Phase 3]

See pricing